- Design
- Systematic review and random-effects meta-analysis
- Population
- 4,043 eyes with neovascular AMD across 16 studies
- Primary outcome
- Baseline features associated with RPE tear
- Effect
- PED height MD 212 µm (95% CI 134–291); PED area MD 5.8 mm² (3.5–8.1)
A systematic review and meta-analysis pooled 16 studies (4,043 eyes) of risk factors for retinal pigment epithelium tears in neovascular age-related macular degeneration, a complication often seen around the start of anti-VEGF treatment.
Eyes that tore had taller pigment epithelial detachments at baseline (mean difference 212 µm, 95% CI 134–291; I² 25%) and larger ones (5.8 mm² larger, 3.5–8.1; I² 3%), and both held up in sensitivity analyses. Fibrovascular PEDs, subretinal fluid, sub-RPE clefts, radial hyperreflective lines and occult or haemorrhagic neovascularisation were also associated. Choice of anti-VEGF agent was not consistently associated.
The evidence is mostly retrospective and unadjusted, and certainty was very low, so these are features to note rather than a validated risk score. They are still useful for counselling: a patient with a tall fibrovascular PED should know before the first injection that a tear is possible.
- Measure and record PED height and area on OCT before starting anti-VEGF in neovascular AMD.
- Note fibrovascular PEDs, sub-RPE clefts and radial hyperreflective lines as features associated with tears.
- Counsel patients with tall or large PEDs about the possibility of a tear before the first injection.
- Do not switch anti-VEGF agent solely to avoid a tear; agent choice was not consistently associated.
Why it matters
It turns a familiar clinical impression into measurable OCT features to document before treatment.
Don't overread it
Very low certainty associations — not a validated prediction tool.
The statistics, in plain English
A standardised mean difference of about 1 is a large separation between eyes that tore and those that did not. Low I² means the studies agreed, but they were mostly small and retrospective, so certainty remains very low.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free